Back to News
Market Impact: 0.15

The Best High-Yield Dividend Stocks to Buy Right Now for Unbeatable Income

HRLEPDNFLXNVDANDAQ
Capital Returns (Dividends / Buybacks)Company FundamentalsCorporate EarningsManagement & GovernanceInflationEnergy Markets & PricesInvestor Sentiment & Positioning
The Best High-Yield Dividend Stocks to Buy Right Now for Unbeatable Income

Hormel Foods (HRL) remains out of favor but increased its dividend by 1%, extending a 60-year streak and yielding ~4.7% while reporting organic sales growth year-over-year in each quarter of 2025 amid weak earnings pressured by inflation and difficulty passing through price increases; the board rehired the prior CEO to drive a turnaround. Enterprise Products Partners (EPD) offers a fee-based midstream business with a 6.2% distribution yield, 27 consecutive years of distribution increases, and distributable cash flow covering the payout by ~1.7x, implying steady distribution growth and income-centric returns for investors.

Analysis

Market structure: EPD (6.2% yield, distributable cash flow coverage ~1.7x) is a beneficiary of fee-based midstream economics — stable volumes and take-or-pay contracts favor predictable cash return to holders. HRL (4.7% yield, 60-year increase streak) is out-of-favor after margin pressure from input cost inflation and limited pricing power; its recent 1% raise signals capital-return priority but limited near-term EPS upside. Cross-asset: both names trade as bond proxies — EPD behaves like a high-yield credit with commodity correlation (throughput/rig counts), HRL like defensive staples; rising rates would compress both equities relative to bonds but boost income-seeking flows into these yields if equities stay stable. Risk assessment: Key tail risks include regulatory changes to midstream tolling/greenhouse rules for EPD, a broad commodity collapse reducing throughput, and a livestock disease or sustained feed-cost shock for HRL. Time horizons: immediate (days–weeks) monitor quarterly DCF and organic sales trends; short-term (1–6 months) watch distribution coverage and input-cost pass-through; long-term (1–3 years) consider secular demand shifts (protein consumption, energy transition). Hidden deps: HRL’s margin recovery hinges on pricing pass-through within one quarter; EPD depends on upstream capex cycles and takeaway capacity. Trade implications: Direct: establish a 2–4% core long in EPD for income, trim if DCF/Distribution coverage falls below 1.25x or if distribution yield compresses >200bp. For HRL, accumulate a 1–3% opportunistic position on pullbacks that push yield ≥5.0% and/or after two consecutive quarters of organic margin improvement. Options: sell 6–12 month covered calls on EPD at strikes ~10–15% OTM to boost yield, and buy 3–6 month puts as protection if DCF coverage nears 1.1x. Pair: long HRL vs short a discretionary consumer ETF (e.g., XLY) into signs of margin recovery. Contrarian angles: Consensus treats HRL as a pure income play; miss is upside from margin normalization — a 100–200bp gross-margin recovery could imply 15–30% equity upside over 12–18 months. EPD’s distribution is priced for carry, not growth — upside is limited absent consolidation or large volume uplifts; the market may be underpricing regulatory risk (a distribution cut would hammer total returns). Historical parallels: midstream rebounds after capex troughs (2016–2018) suggest patience can pay, but reliance on upstream health is the key second-order risk.